Edition:
United States

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

0.70USD
19 Jun 2018
Change (% chg)

-- (--)
Prev Close
$0.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
60,295
52-wk High
$1.52
52-wk Low
$0.62

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.15 December 20 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 5 5 6 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.43 2.43 2.50 2.43

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 5 0.00 0.02 0.00 5.30
Quarter Ending Sep-18 5 0.00 0.02 0.00 7.75
Year Ending Dec-18 6 0.03 0.10 0.00 12.80
Year Ending Dec-19 6 0.03 0.10 0.00 32.15
Earnings (per share)
Quarter Ending Jun-18 5 -0.15 -0.12 -0.17 -0.09
Quarter Ending Sep-18 5 -0.15 -0.11 -0.19 -0.01
Year Ending Dec-18 6 -0.57 -0.37 -0.74 -0.90
Year Ending Dec-19 6 -0.51 -0.24 -0.69 -1.15

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.00 0.02 0.01 400.00
Quarter Ending Dec-17 0.74 0.02 0.72 97.56
Quarter Ending Sep-17 0.86 0.02 0.85 97.92
Quarter Ending Jun-17 0.87 0.02 0.85 97.94
Quarter Ending Mar-17 0.94 0.02 0.93 98.09

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 5.30
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 7.75
Year Ending Dec-18 0.03 0.03 0.03 0.02 12.80
Year Ending Dec-19 0.03 0.03 0.03 0.60 32.15

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings